Reading this on a mobile device? Try our optimized mobile version here:

March 6, 2013News for medical technology professionals

  Top Story 
  • Philips gets FDA OK for cardiac image-guidance system
    The FDA has given Philips 510(k) clearance for its EchoNavigator system, which is used to guide cardiac surgeons and interventional cardiologists during structural heart disease repairs. The technology also has CE mark approval in Europe and works by providing a combined view of live 3D ultrasound and X-ray images. (3/5) LinkedInFacebookTwitterEmail this Story
The odds of receiving an Inspectional Observation (483) or a subsequent Warning Letter have been sharply on the rise, and the seriousness of each remains high. How do you respond?
  Business & Market Trends 
  International Developments 
Eucomed represents the medical technology industry in Europe. Our mission is to make modern, innovative and reliable medical technology available to more people. AdvaMed and Eucomed partner on issues of mutual interest.
  • Medtronic gains expanded EU approval for drug-eluting stent
    European regulators have expanded approval for Medtronic's Resolute Integrity device to include one month of dual-antiplatelet treatment, which the company says is the shortest treatment indication for that type of device. Patients who discontinued or interrupted DAP treatment at least a month after implantation showed low rates of stent thrombosis in a clinical study, according to the drug-eluting stent's new labeling. (Boston) (3/5) LinkedInFacebookTwitterEmail this Story
  • EU approves Bolton Medical's abdominal stent graft
    Bolton Medical has earned the CE mark in Europe for its Treovance system, which is used to treat abdominal aortic aneurysms with up to 10 millimeters of proximal neck length or up to 75 degrees of infrarenal neck angle. The stent graft is designed to support multiple configurations that match individual patient anatomies. (3/4) LinkedInFacebookTwitterEmail this Story
  Science & Health 
  Emerging Technologies 
  • AccuVein unveils new version of vein illumination device
    AccuVein has released the AV400, an updated version of its vein illumination system that can visualize the vasculature up to 10 millimeters deep. The handheld device uses a single button for activation and comes with a hands-free mode to enable guided intravenous starts and blood draws, among other features. (3/5) LinkedInFacebookTwitterEmail this Story
  • Self-retaining surgical ratchet from Symmetry is launched
    Symmetry Medical has announced the launch of its Bookwalter Self-Retaining Rotilt Ratchet, which allows for retraction in any position and supports multiple configurations. The surgical device was unveiled at a recent perioperative nurses conference in San Diego. (3/5) LinkedInFacebookTwitterEmail this Story

Interested in learning more about advertising with SmartBrief? Click here for detailed industry information and media kits. 

  Government & Regulatory 
  • House Republicans ask FDA to clarify proposed mHealth regulations
    House Energy and Commerce Committee Chairman Fred Upton, R-Mich., and other Republican House members have asked FDA Commissioner Dr. Margaret Hamburg via a letter sent on March 1 to provide clarity on the agency's proposal to regulate certain mobile health applications. The legislators expressed concern that manufacturers of mHealth apps, smartphones and tablets could be subjected to the 2.3% tax under the health care law if the FDA decides to regulate them as medical devices. (3/6) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • Navigating the SEC's New Conflict Minerals Disclosure Requirements
    Thursday, April 11
    Webinar, 1:00 p.m. - 2:00 p.m. EST
    The SEC recently approved the much-debated conflict minerals due-diligence disclosure rules that were originally developed in the Dodd-Frank Wall Street Reform and Consumer Protection Act. The rule requires public companies to disclose the use of any conflict minerals that “are necessary to the functionality or production of a product manufactured” or “contracted to be manufactured” by that company. While not banning the use of conflict minerals, it does require companies to assess their supply chains and publically disclose their use of the minerals. When your company is producing either components or finished medical devices for customers, you will need to understand the nuances of your supply-chain position in relation to the SEC's rule. Learn more about SEC’s rule in this comprehensive webinar. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
  • Join the AdvaMed-MTLI LinkedIn group!
    Build close relationships with member companies, both small and large, and receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Interact in discussions that leverage the leadership and expertise of the medical technology industry. This social group is full of key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Aside from practical learning opportunities, this LinkedIn group provides the premier opportunity to network with key players from virtually every aspect of the industry. Link to the AdvaMed MTLI LinkedIn group page. LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

Position TitleCompany NameLocation
Sales Area Manager/Sales Rep of Neurovascular Intervention ProductsAsahi Intecc USA, Inc.Any location in US, CA
Compliance Consultant 2DJO GlobalVista, CA
Accreditation ManagerAmerican Association of Tissue BanksMcLean, VA
Director, Health Care ComplianceRTI BiologicsAlachua, FL
Director of Global Infrastructure - 002196Edwards LifesciencesIrvine, CA
Manager, HCL Regulatory & Quality ComplianceOwens & MinorLouisville, KY
DIR OPERATIONS, Milpitas Site - 130000007RAbbott San Jose, CA
Engineer, Process DevelopmentArthroCare CorporationIrvine, CA
Legal Counsel IIMedtronic, Inc.Minneapolis, MN or Washington, DC, United States
Biostatistician - Post Market Surveillance Johnson & JohnsonRaynham, MA
Click here to view more job listings.

Every time you spend money, you're casting a vote for the kind of world you want."
--Anna Lappé,
American writer, speaker and activist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
A powerful website for SmartBrief readers including:
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information